Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Antibiotics Deconstructed
Clinical Forum Insights

Subscribe

  • News
  • Watch
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Mai-Chi N. Tran, PharmD, BCPS

Advertisement

Articles by Mai-Chi N. Tran, PharmD, BCPS

Investigational Treatments for Clostridioides difficile Infection

ByRavina Kullar, PharmD, MPH, FIDSA*,Mai-Chi N. Tran, PharmD, BCPS,Ellie J.C. Goldstein, MD, FIDSA, FSHEA
October 10th 2019

The high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.

Advertisement

Latest Updated Articles

  • Investigational Treatments for Clostridioides difficile Infection
    Investigational Treatments for Clostridioides difficile Infection

    October 10th 2019



Advertisement
Advertisement

Trending on Contagion Live

1

Loss of Measles Elimination Exposes MMR Gaps, Titer Testing Surges in Outbreak Areas

2

IDSA 2026 AMR Guidance Puts Resistance Mechanisms at Center of Therapy

3

Ebola Outbreak Reaches 11,145 Cases, 5437 Deaths

4

Cefazolin Possibly Superior, Probably Safer than Cloxacillin for MSSA Bacteremia

5

WHO Reports 2 MERS Cases in Qatar, First Since 2022

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us